Etesian Wealth Advisors Inc. lowered its stake in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 4.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,867 shares of the company’s stock after selling 1,837 shares during the quarter. Etesian Wealth Advisors Inc.’s holdings in Exelon were worth $1,388,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Stephens Consulting LLC grew its holdings in Exelon by 78.1% in the 4th quarter. Stephens Consulting LLC now owns 782 shares of the company’s stock valued at $29,000 after buying an additional 343 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Exelon in the third quarter valued at approximately $32,000. Brown Lisle Cummings Inc. bought a new position in Exelon during the fourth quarter worth $30,000. Crews Bank & Trust acquired a new position in Exelon during the 4th quarter valued at $34,000. Finally, Versant Capital Management Inc grew its position in Exelon by 56.7% in the 4th quarter. Versant Capital Management Inc now owns 1,047 shares of the company’s stock worth $39,000 after purchasing an additional 379 shares during the last quarter. Institutional investors own 80.92% of the company’s stock.
Exelon Stock Up 1.2 %
Shares of NASDAQ:EXC opened at $41.04 on Thursday. The company has a market capitalization of $41.24 billion, a PE ratio of 16.89, a P/E/G ratio of 2.66 and a beta of 0.56. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.97 and a current ratio of 1.09. The company’s fifty day moving average is $38.30 and its 200-day moving average is $38.65. Exelon Co. has a 52 week low of $33.35 and a 52 week high of $41.26.
Insiders Place Their Bets
Wall Street Analyst Weigh In
EXC has been the subject of a number of research analyst reports. Barclays cut their price objective on shares of Exelon from $44.00 to $42.00 and set an “overweight” rating for the company in a research report on Wednesday, January 22nd. Guggenheim raised Exelon from a “neutral” rating to a “buy” rating in a report on Thursday, January 23rd. Scotiabank boosted their price objective on Exelon from $40.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, December 12th. Morgan Stanley reduced their target price on Exelon from $46.00 to $44.00 and set an “equal weight” rating for the company in a research report on Friday, November 22nd. Finally, Evercore ISI raised shares of Exelon from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $43.00 to $44.00 in a report on Tuesday, January 21st. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Exelon currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.13.
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Read More
- Five stocks we like better than Exelon
- How to Use Stock Screeners to Find Stocks
- Powering Profits: Utility Stocks That Shine in Volatility
- What does consumer price index measure?
- Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead?
- Are Penny Stocks a Good Fit for Your Portfolio?
- RTX and Lockheed Martin: Buy 1 for Today and 1 for Tomorrow
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXC – Free Report).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.